Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Costall

Showing results (281-290 of 294) with videos related to

Pageof 30
Sort By:
Clinical Neuropharmacology|January 1, 1992
Pharmacological profile of the atypical neuroleptic sertindoleJ Hyttel, J Arnt, B Costall, et al.
Journal of Cardiovascular Pharmacology|January 1, 1992
Angiotensin-converting enzyme inhibition, angiotensin, and cognitionJ M Barnes, N M Barnes, B Costall, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1990
Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activityJ Hughes, P Boden, B Costall, et al.
Psychopharmacology|August 25, 2000
Anxiolytic profile of ropinirole in the rat, mouse and common marmosetD C Rogers, B Costall, A M Domeney, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 1, 1992
Pharmacological comparison of the sigma recognition site labelled by [3H]haloperidol in human and rat cerebellumJ M Barnes, N M Barnes, P C Barber, et al.
Journal of Medicinal Chemistry|August 1, 1979
N-Alkyl derivatives of (+/-)-alpha-methyldopamineJ G Cannon, Z Perez, J P Long, et al.
Journal of Medicinal Chemistry|February 1, 1981
5,7-Dihydroxy-2-aminotetralin derivatives: synthesis and assessment of dopaminergic and adrenergic actionsJ G Cannon, A N Brubaker, J P Long, et al.
Pharmacology, Biochemistry, and Behavior|September 1, 1991
The effects of umespirone as a potential anxiolytic and antipsychotic agentN M Barnes, B Costall, A M Domeney, et al.
Pharmacology, Biochemistry, and Behavior|December 1, 1990
The differential activities of R (+)- and S(-)-zacopride as 5-HT3 receptor antagonistsJ M Barnes, N M Barnes, B Costall, et al.
Pharmacology, Biochemistry, and Behavior|January 1, 1991
Preclinical pharmacology of ropinirole (SK&F 101468-A) a novel dopamine D2 agonistR J Eden, B Costall, A M Domeney, et al.
Pageof 30

Showing results (281-290 of 294) with videos related to

Sort By:
Pageof 30
Clinical Neuropharmacology|January 1, 1992
Pharmacological profile of the atypical neuroleptic sertindoleJ Hyttel, J Arnt, B Costall, et al.
Journal of Cardiovascular Pharmacology|January 1, 1992
Angiotensin-converting enzyme inhibition, angiotensin, and cognitionJ M Barnes, N M Barnes, B Costall, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1990
Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activityJ Hughes, P Boden, B Costall, et al.
Psychopharmacology|August 25, 2000
Anxiolytic profile of ropinirole in the rat, mouse and common marmosetD C Rogers, B Costall, A M Domeney, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 1, 1992
Pharmacological comparison of the sigma recognition site labelled by [3H]haloperidol in human and rat cerebellumJ M Barnes, N M Barnes, P C Barber, et al.
Journal of Medicinal Chemistry|August 1, 1979
N-Alkyl derivatives of (+/-)-alpha-methyldopamineJ G Cannon, Z Perez, J P Long, et al.
Journal of Medicinal Chemistry|February 1, 1981
5,7-Dihydroxy-2-aminotetralin derivatives: synthesis and assessment of dopaminergic and adrenergic actionsJ G Cannon, A N Brubaker, J P Long, et al.
Pharmacology, Biochemistry, and Behavior|September 1, 1991
The effects of umespirone as a potential anxiolytic and antipsychotic agentN M Barnes, B Costall, A M Domeney, et al.
Pharmacology, Biochemistry, and Behavior|December 1, 1990
The differential activities of R (+)- and S(-)-zacopride as 5-HT3 receptor antagonistsJ M Barnes, N M Barnes, B Costall, et al.
Pharmacology, Biochemistry, and Behavior|January 1, 1991
Preclinical pharmacology of ropinirole (SK&F 101468-A) a novel dopamine D2 agonistR J Eden, B Costall, A M Domeney, et al.
Pageof 30